ALPHAMAB ONCOLOGY

Analyst Reco. Alphamab Oncology

Equities

9966

KYG0330A1013

Market Closed - Hong Kong S.E. Other stock markets 04:08:24 2024-06-06 am EDT			5-day change	1st Jan Change
2.88 ^HKD	-4.64%		+18.52%	-56.63%

Jun. 05	ArriVent, Alphamab Unit to Collaborate on Antibody Drug Conjugates For Cancer Treatment	MT
Jun. 05	Alphamab Strikes Deal with Nasdaq-Listed ArriVent to Co-Develop Antibody Drug Conjugates	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

UBS Adjusts Alphamab Oncology's Price Target to HK$12.94 From HK$13.22, Keeps at Buy	22-09-07	MT
Nomura Adjusts Alphamab Oncology's Price Target to HK$13.22 From HK$13.89, Keeps at Buy	22-04-04	MT
ALPHAMAB ONCOLOGY : Nomura Adjusts Alphamab Oncology's Price Target to HK$28.8 From HK$25.1, Keeps at Buy	21-05-25	MT
ALPHAMAB ONCOLOGY : Nomura Adjusts Alphamab Oncology's Price Target to HK$25.1 From HK$17.2, Keeps at Buy	21-05-12	MT
ALPHAMAB ONCOLOGY : Nomura Starts Alphamab Oncology at Buy With HK$17.2 Price Target	21-01-28	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer